NM_001303007.2:c.854G>T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001303007.2(DDAH2):​c.854G>T​(p.Ser285Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,459,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

DDAH2
NM_001303007.2 missense

Scores

4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.59

Publications

0 publications found
Variant links:
Genes affected
DDAH2 (HGNC:2716): (DDAH family member 2, ADMA-independent) This gene encodes a dimethylarginine dimethylaminohydrolase. The encoded enzyme functions in nitric oxide generation by regulating the cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. The protein may be localized to the mitochondria. Alternative splicing resulting in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07848024).
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DDAH2NM_001303007.2 linkc.854G>T p.Ser285Ile missense_variant Exon 6 of 6 ENST00000375789.7 NP_001289936.1 O95865V9HW53
DDAH2NM_001303008.2 linkc.854G>T p.Ser285Ile missense_variant Exon 7 of 7 NP_001289937.1 O95865V9HW53
DDAH2NM_013974.3 linkc.854G>T p.Ser285Ile missense_variant Exon 7 of 7 NP_039268.1 O95865V9HW53
DDAH2XM_011514448.3 linkc.854G>T p.Ser285Ile missense_variant Exon 7 of 7 XP_011512750.1 O95865V9HW53

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DDAH2ENST00000375789.7 linkc.854G>T p.Ser285Ile missense_variant Exon 6 of 6 2 NM_001303007.2 ENSP00000364945.2 O95865

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000813
AC:
2
AN:
245888
AF XY:
0.00000745
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000548
AC:
8
AN:
1459574
Hom.:
0
Cov.:
30
AF XY:
0.00000826
AC XY:
6
AN XY:
726198
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33462
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52306
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110938
Other (OTH)
AF:
0.00
AC:
0
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000853
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 25, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.854G>T (p.S285I) alteration is located in exon 7 (coding exon 6) of the DDAH2 gene. This alteration results from a G to T substitution at nucleotide position 854, causing the serine (S) at amino acid position 285 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.011
T;T;T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.70
D
M_CAP
Benign
0.0066
T
MetaRNN
Benign
0.078
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.14
N;N;N
PhyloP100
2.6
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
1.0
N;N;N
REVEL
Benign
0.24
Sift
Uncertain
0.0050
D;D;D
Sift4G
Uncertain
0.0090
D;D;D
Polyphen
0.39
B;B;B
Vest4
0.24
MutPred
0.27
Loss of disorder (P = 0.0015);Loss of disorder (P = 0.0015);Loss of disorder (P = 0.0015);
MVP
0.043
MPC
1.6
ClinPred
0.37
T
GERP RS
3.5
Varity_R
0.11
gMVP
0.44
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777018614; hg19: chr6-31695018; API